WHO ICTRP trial
A Randomized Controlled Study on Tirofiban Combined with Nimodipine for Early…
ChiCTR2500105760 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500105760 |
|---|---|
| Public title | A Randomized Controlled Study on Tirofiban Combined with Nimodipine for Early Neurological Deterioration in Small Artery Occlusive Cerebral Infarction |
| Scientific title | A Randomized Controlled Trial on the Efficacy and Safety of Tirofiban Combined with Nimodipine in the Treatment of Early Neurological Deterioration in Small Artery Occlusive Cerebral Infarction |
| Primary sponsor | Xiushan Tujia and Miao Autonomous County People's Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Small Artery Occlusive Cerebral Infarction |
| Interventions | Combination therapy group:Tirofiban (loading dose: 0.4 µg/kg/min; maintenance infusion: 0.1 µg/kg/min for 48 hours) combined with Nimodipine (continuous infusion: 2 mg/h via syringe pump for 48 hours).Plus standard care: All patients… |
| Registration date | Jul 10, 2025 |
| Target size | Combination therapy group:73;Monotherapy group:73 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: